Home - Products - Others - Other Targets - Big Endothelin -1 (1-39), porcine

Big Endothelin -1 (1-39), porcine

CAS No. 124834-83-9

Big Endothelin -1 (1-39), porcine( ——— )

Catalog No. M41120 CAS No. 124834-83-9

Big Endothelin -1 (1-39), porcine

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Big Endothelin -1 (1-39), porcine
  • Note
    Research use only, not for human use.
  • Brief Description
    Big Endothelin -1 (1-39), porcine
  • Description
    Big Endothelin -1 (1-39), porcine
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    124834-83-9
  • Formula Weight
    4370.7
  • Molecular Formula
    C192H287N49O58S5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • JNJ-26489112

    JNJ-26489112 (JNJ26489112) is a broad-spectrum anticonvulsant that displays activity in rodents against audiogenic, electrically-induced, and chemically-induced seizures.

  • 1-Cinnamoylpyrrolidi...

    1-Cinnamoylpyrrolidine, a natural product prepared from Piper caninum, can be used as a DNA strand breaking agent, inducing the relaxation of the plasmid pBR322 DNA superhelix in the presence of Cu2+. 1-Cinnamoylpyrrolidine inhibits PAF-induced platelet aggregation with an IC50 value of 37.3 μM. value was 37.3 μM.

  • Flumethasone pivalat...

    Flumethasone pivalate has antipruritic, anti-inflammatory, and vasoconstrictive properties and can be used in studies about adrenocortical suppression, cutaneous atrophy, plasma transcortin binding, and telangiectasia.